[So-called uremic heart diseases]
- PMID: 2108635
[So-called uremic heart diseases]
Abstract
The overall cardiovascular mortality in patients with chronic renal failure is about 30 per cent of which 10 per cent is attributed to myocardial infarction. This prevalence led some workers to propose a hypothesis of "accelerated atherosclerosis" due to the hyperlipidaemia observed in 30 to 70 per cent of patients. However, the concept of accelerated atherosclerosis, which was based essentially on clinical studies, has been questioned. Pericardial effusion is a common complication of chronic renal failure and has been reported in over 62 per cent of patients in echocardiographic studies. There are many causes and symptoms are often mild; systematic echocardiographic examination of patients with renal failure undergoing haemodialysis has shown 32 per cent of pericardial effusions to be asymptomatic. There are two potential complications: cardiac tamponade and, lesser frequently, constrictive pericarditis. Cardiac failure is a common cause of death in patients undergoing long-term dialysis. The myocardial histological appearances are those of fibrosis, the etiology of which is not fully understood although the dialysis membranes and hypotensive episodes occurring during haemodialysis have been thought to play a role. Left ventricular hypertrophy and fibrosis may give rise to ventricular arrhythmias which could explain some of the cases of sudden death observed in patients with renal failure and often wrongly attributed to ischemic heart disease. Another form of myocardial disease which is observed later is characterised by an alteration of systolic function with left ventricular dilatation and hypokinesia and increased end diastolic pressures without an increase in left ventricular wall thickness. Valvular heart disease may also result from renal failure.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Heart failure in patients with chronic kidney disease.Rocz Akad Med Bialymst. 2004;49:162-5. Rocz Akad Med Bialymst. 2004. PMID: 15631334 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.Q J Med. 1977 Apr;46(182):197-214. Q J Med. 1977. PMID: 325593
-
[Cardiovascular repercussions of chronic hemodialysis].Rev Prat. 1990 Mar 1;40(7):625-9. Rev Prat. 1990. PMID: 2326588 French.
-
[Conditions and consequences of cardiac alterations in patients with end-stage renal disease on maintenance hemodialysis].Postepy Hig Med Dosw. 1996;50(3):277-91. Postepy Hig Med Dosw. 1996. PMID: 8927587 Review. Polish.
Cited by
-
Uraemic Cardiomyopathy: A Review of Current Literature.Clin Med Insights Cardiol. 2021 Feb 23;15:1179546821998347. doi: 10.1177/1179546821998347. eCollection 2021. Clin Med Insights Cardiol. 2021. PMID: 33707979 Free PMC article. Review.
-
Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle.Front Med (Lausanne). 2018 Jul 24;5:206. doi: 10.3389/fmed.2018.00206. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30087898 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical